Analyst Price Target is $201.25
▲ +1,663,123.14% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for DiaSorin in the last 3 months. The average price target is $201.25, with a high forecast of $201.25 and a low forecast of $201.25. The average price target represents a 1,663,123.14% upside from the last price of $0.01.
Current Consensus is
The current consensus among 6 investment analysts is to hold stock in DiaSorin. This rating has held steady since May 2020, when it changed from a Buy consensus rating.
DiaSorin SpA engages in the development, production, and marketing of reagent kits for in vitro diagnostics. It specializes in the provision of immunodiagnostics and molecular diagnostics solutions which meet the needs of the following clinical areas: infectious diseases, cardiac markers, bone metabolism, hepatitis & retrovirus, oncology and endocrinology. The company was founded in 1968 and is headquartered in Vercelli, Italy.